Early treatment with HCQ+AZ+Z results in 84% lower hospitalization and 80% lower death - hospitalization OR 0.16 (p<0.001), death OR 0.2 (p=0.16). No cardiac side effects. Retrospective 518 patients (141 treated, 377 control).. https://t.co/6kSnAjd8Ro #c19study
— キリエ (@KiryeNet) August 7, 2020
https://twitter.com/KiryeNet/status/1291807854538526720
Early treatment with HCQ+AZ+Z results in 84% lower hospitalization and 80% lower death - hospitalization OR 0.16 (p<0.001), death OR 0.2 (p=0.16). No cardiac side effects. Retrospective 518 patients (141 treated, 377 control).. https://c19study.com/scholz.html #c19study
